OnabotulinumtoxinA (BOTOX®)A Review of its Use in the Prophylaxis of Headaches in Adults with Chronic Migraine

被引：0
|
作者：
James E. Frampton
机构：
[1] Adis,
来源：
Drugs | 2012年 / 72卷
关键词：
Migraine; Topiramate; Chronic Migraine; Medication Overuse; OnabotulinumtoxinA;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
This article reviews the pharmacology, therapeutic efficacy and tolerability profile of intramuscularly injected onabotulinumtoxinA (onaBoNTA; BOTOX®) for headache prophylaxis in adults with chronic migraine, with a focus on UK labelling for the drug. The pharmacological actions of onaBoNTA include a direct antinociceptive (analgesic) effect; while not fully understood, the mechanism of action underlying its headache prophylaxis effect in chronic migraine is presumed to involve inhibition of peripheral and central sensitization in trigemino-vascular neurones.
引用
收藏
页码：825 / 845
页数：20
相关论文
共 50 条
  • [41] OnabotulinumtoxinA in Chronic Migraine: A Profile of Its Use (vol 34, pg 1287, 2020)
    Frampton, James E.
    CNS DRUGS, 2021, 35 (01) : 135 - 135
  • [42] The significance of the circadian time of administration on the effectiveness and tolerability of OnabotulinumtoxinA for chronic migraine prophylaxis
    Dermitzakis, E.
    Vikelis, M.
    Argyriou, A.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [43] Prospective analysis of the use of onabotulinumtoxina (botox®) In the treatment of chronic migraine; real-life data in 299 patients from hull, UK
    Khalil, M.
    Zafar, H.
    Quarshie, V.
    Ahmed, F.
    JOURNAL OF HEADACHE AND PAIN, 2014, 15
  • [44] Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, UK
    Modar Khalil
    Hassan W Zafar
    Victoria Quarshie
    Fayyaz Ahmed
    The Journal of Headache and Pain, 2014, 15
  • [45] Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, UK
    Khalil, Modar
    Zafar, Hassan W.
    Quarshie, Victoria
    Ahmed, Fayyaz
    JOURNAL OF HEADACHE AND PAIN, 2014, 15
  • [46] Use of amitriptyline and fluoxetine in prophylaxis of migraine and tension-type headaches
    Oguzhanoglu, A
    Sahiner, T
    Kurt, T
    Akalin, O
    CEPHALALGIA, 1999, 19 (05) : 531 - 532
  • [47] OnabotulinumtoxinA for the preventive treatment of chronic migraine in older adults: A retrospective study
    Soh, P.
    Grosberg, B. M.
    Verhaak, A.
    HEADACHE, 2022, 62 : 153 - 154
  • [48] OnabotulinumtoxinA (Botox) for chronic migraine during pregnancy: experience from Hull (UK) headache clinic for 10 years
    Ahmed, Fayyaz
    Wong, Ho-Tin
    Khalil, Modar
    Nasergivehchi, Somayeh
    CEPHALALGIA, 2022, 42 (1_SUPPL) : 134 - 134
  • [49] 10 Year follow up on 337 patients receiving OnabotulinumtoxinA (Botox) for Chronic Migraine, data from the Hull (UK) Migraine Clinic
    Khan, Rafiullah
    Delrosario, Helen
    Khalil, Modar
    Dorsey, Sophie
    Ijaz, Aamir
    Ahmed, Fayyaz
    CEPHALALGIA, 2023, 43 (1supp)
  • [50] Onabotulinumtoxina prophylaxis in chronic migraine utilization and patient characteristics: observational study in the European Union
    Matharu, M.
    Pascual, J.
    Remahl, I. Nilsson
    Odom, D.
    Gutierrez, L.
    Andrews, E.
    Largent, J.
    Johannes, C.
    JOURNAL OF HEADACHE AND PAIN, 2014, 15
12345